関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|
| 反応物 | Diisopropylethylamine | HCID 81531 | — |
| 反応物 | tert-Butyl piperazine-1-carboxylate | HCID 143452 | — |
| 反応物 | 4-(Chloromethyl)-2-(propan-2-yl)-1,3-oxazole | HCID 2763291 | — |
| 溶媒 | Dichloromethane | HCID 6344 | — |
| 溶媒 | Ethyl Acetate | HCID 8857 | — |
| 生成物 | tert-Butyl 4-((2-isopropyloxazol-4-yl)methyl)piperazine-1-carboxylate | HCID 46867020 | 99% |
反応手順
4-(Chloromethyl)-2-isopropyloxazole (0.920 g, 5.75 mmol, 1 eq) was suspended in DCM (9 mL). DIPEA (2.5 mL, 14.4 mmol, 2.5 eq) was added dropwise, followed by N-Boc-piperazine (2.350 g, 12.6 mmol, 2.2 eq). The reaction mixture was stirred at 35° C. for 17 h, then diluted with EtOAc, washed with H2O, and brine. The organic layer was separated, dried (MgSO4) and the solvent removed in vacuo. The crude product was purified by column chromatography on a Biotage SP1 system (DCM/EtOAc; v/v 1:1) to give the title compound (1.760 g, 99%); 1H-NMR (500 MHz, CDCl3): δ 1.33 (d, J=5.5 Hz, 6H, iPr—CH3), 1.45 (s, 9H, C(CH3)3), 2.45 (br t, J=4.8 Hz, 4H, piperazine N(CH2)2), 3.07 (m, 1H, iPr—CH), 3.41-3.50 (m, 6H, piperazine N(CH2)2 and NCH2), 7.41 (s, 1H, oxazole 5-H); LC (Method B)-MS (ESI, m/z): Rt=2.51 min—310 [(M+H)+, 100%].
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 特許番号 | US08088761B2 |
|---|
| 出典データセット | uspto-grants-2012_01 |
|---|
| ORD ID | ord-f5b8115fff534e14913fab0c94b18b51 |
|---|
| 出典メモ | uspto-grants-2012_01 |
|---|